US regulators want to know why drug price transparency rules are not working

US regulators are asking for public input on why new rules for disclosing prescription drug prices are not being followed. They want to know what changes are needed to make sure health plans actually publish accurate drug price data.

The US government passed a law to make healthcare prices transparent, including drug prices. The idea was that if people could see prices, they would shop around and costs would go down. But health plans are not publishing the data in a usable way, or at all. This request for information means the government is trying to figure out how to enforce its own rules.